AGMBQT11AgomAb Therapeutics N.V. American Depositary Shares·NASDAQ
6.72-10.28%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 22, 20264Statement of changes in beneficial ownership
Oct 13, 20266-KForeign issuer report
Oct 09, 20264Statement of changes in beneficial ownership
Oct 07, 20264Statement of changes in beneficial ownership
Oct 07, 20264Statement of changes in beneficial ownership
Oct 07, 20264Statement of changes in beneficial ownership
Oct 01, 20266-KForeign issuer report
Sep 15, 20263Initial statement of beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20263Initial statement of beneficial ownership
Sep 14, 20266-KForeign issuer report
Sep 11, 20266-KForeign issuer report
Aug 10, 20266-KForeign issuer report
Aug 06, 20266-KForeign issuer report
Jun 23, 20266-KForeign issuer report
May 27, 20266-KForeign issuer report
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 06, 2026SC 13GBeneficial ownership statement (passive)
Apr 24, 20266-KForeign issuer report
Apr 23, 202620-FAnnual report (foreign issuers)
Apr 16, 2026SC 13GBeneficial ownership statement (passive)
Mar 18, 20263Initial statement of beneficial ownership
Mar 18, 20263Initial statement of beneficial ownership